tiprankstipranks
Inspiration Healthcare Group PLC (GB:IHC)
LSE:IHC

Inspiration Healthcare (IHC) AI Stock Analysis

5 Followers

Top Page

GB:IHC

Inspiration Healthcare

(LSE:IHC)

Select Model
Select Model
Select Model
Neutral 52 (OpenAI - 5.2)
Rating:52Neutral
Price Target:
27.00 p
▲(83.05% Upside)
Action:ReiteratedDate:02/28/26
The score is primarily held back by weak financial performance, including worsening losses, reduced margins, rising leverage, and negative operating/free cash flow. Technicals are a partial offset with strong trend and MACD, but overbought RSI/Stoch readings add near-term risk. Valuation is constrained by a negative P/E, consistent with ongoing unprofitability.
Positive Factors
Niche clinical focus
A specialized focus on neonatal and respiratory acute-care devices creates durable clinical differentiation. Hospitals and NICUs value proven, specialized equipment, which supports long procurement cycles, installed-base durability and higher switching costs versus generalist suppliers.
Negative Factors
Worsening profitability and margins
Declining gross margins and rising net losses indicate structural margin pressure or unfavorable product mix. Persistent negative EBIT/EBITDA reduces reinvestment capacity, weakens pricing power or cost control, and makes sustained profitability recovery harder absent business-model improvements.
Read all positive and negative factors
Positive Factors
Negative Factors
Niche clinical focus
A specialized focus on neonatal and respiratory acute-care devices creates durable clinical differentiation. Hospitals and NICUs value proven, specialized equipment, which supports long procurement cycles, installed-base durability and higher switching costs versus generalist suppliers.
Read all positive factors

Inspiration Healthcare (IHC) vs. iShares MSCI United Kingdom ETF (EWC)

Inspiration Healthcare Business Overview & Revenue Model

Company Description
Inspiration Healthcare Group plc, together with its subsidiaries, supplies medical technology for critical care, operating theatre, and home healthcare applications worldwide. The company provides neonatal intensive care products, such as inspirat...
How the Company Makes Money
Inspiration Healthcare generates revenue primarily through the sale of its medical devices and equipment to hospitals, healthcare providers, and distributors. Key revenue streams include direct sales of respiratory support devices, patient monitor...

Inspiration Healthcare Financial Statement Overview

Summary
Overall financials indicate pressure across profitability, leverage, and cash generation. Net losses have increased, gross margin fell to 42.82% (from 47.55%), leverage rose (debt-to-equity 0.90) alongside a sharp drop in equity, and 2025 operating/free cash flow were negative—raising liquidity and execution risk.
Income Statement
45
Neutral
Balance Sheet
50
Neutral
Cash Flow
40
Negative
BreakdownTTMJan 2024Jan 2023Jan 2022Jan 2021Jan 2020
Income Statement
Total Revenue45.20M38.25M37.63M41.23M41.05M36.98M
Gross Profit20.06M16.38M17.89M17.63M20.25M17.14M
EBITDA-9.09M-12.44M-2.43M2.76M6.17M4.47M
Net Income-11.44M-14.97M-6.03M272.00K4.23M2.81M
Balance Sheet
Total Assets36.71M41.08M49.01M54.89M50.11M43.23M
Cash, Cash Equivalents and Short-Term Investments620.00K733.00K609.00K2.28M9.25M10.65M
Total Debt12.91M14.97M12.83M13.08M7.54M3.17M
Total Liabilities20.34M24.45M20.05M19.42M14.62M11.66M
Stockholders Equity16.37M16.64M28.97M35.47M35.49M31.58M
Cash Flow
Free Cash Flow3.05M-3.52M380.00K-11.86M-436.00K3.79M
Operating Cash Flow3.62M-1.55M2.01M-3.52M3.54M4.71M
Investing Cash Flow-2.63M-1.74M-2.69M-8.34M-3.97M-14.06M
Financing Cash Flow-2.88M3.61M-1.19M4.88M-964.00K15.53M

Inspiration Healthcare Technical Analysis

Technical Analysis Sentiment
Positive
Last Price14.75
Price Trends
50DMA
20.70
Positive
100DMA
18.83
Positive
200DMA
20.13
Positive
Market Momentum
MACD
-0.14
Positive
RSI
45.59
Neutral
STOCH
42.61
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:IHC, the sentiment is Positive. The current price of 14.75 is below the 20-day moving average (MA) of 23.20, below the 50-day MA of 20.70, and below the 200-day MA of 20.13, indicating a neutral trend. The MACD of -0.14 indicates Positive momentum. The RSI at 45.59 is Neutral, neither overbought nor oversold. The STOCH value of 42.61 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GB:IHC.

Inspiration Healthcare Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
£177.35M12.6023.64%3.48%10.80%1.75%
70
Outperform
£10.30B22.6411.79%2.35%2.51%56.56%
67
Neutral
£4.29B37.0810.53%2.11%4.18%37.65%
56
Neutral
£430.64M47.213.87%1.25%68.03%-18.27%
52
Neutral
£19.19M-18.39-69.35%31.78%10.27%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
43
Neutral
£4.20M77.73-16.78%-4.98%-114.29%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
GB:IHC
Inspiration Healthcare
21.40
4.65
27.76%
GB:AMS
Advanced Medical Solutions
199.00
4.47
2.30%
GB:CTEC
ConvaTec
220.00
-11.72
-5.06%
GB:SUN
Surgical Innovations
0.45
-0.05
-10.00%
GB:TSTL
Tristel
370.00
110.25
42.45%
GB:SN
Smith & Nephew
1,207.50
250.74
26.21%

Inspiration Healthcare Corporate Events

Business Operations and Strategy
Inspiration Healthcare Wins Four-Year NHS Neonatal Ventilator Framework
Positive
Mar 5, 2026
Inspiration Healthcare has secured re-appointment to the NHS Supply Chain framework as an approved supplier of neonatal respiratory care equipment for England and Wales for a further four years. The company has also been ranked the number one neon...
Business Operations and StrategyFinancial Disclosures
Inspiration Healthcare lifts revenue 24% and secures major US ventilator deal
Positive
Feb 12, 2026
Inspiration Healthcare Group reported a strong FY26 performance, with revenue rising 24% to £47.5 million, slightly above market expectations, driven by a robust second half and improved execution under its “Back to Basics” strate...
Business Operations and Strategy
Inspiration Healthcare Appoints Cavendish as Joint Broker to Bolster Market Support
Positive
Feb 3, 2026
Inspiration Healthcare Group has appointed Cavendish Capital Markets Limited as a joint broker with immediate effect, working alongside its existing nominated adviser and corporate broker Panmure Liberum. The move is expected to strengthen the AIM...
Business Operations and Strategy
Inspiration Healthcare’s Airon Wins Major Three-Year US Ventilator Deal
Positive
Jan 28, 2026
Inspiration Healthcare’s US subsidiary, Airon Corporation, has signed a three-year purchasing agreement with a major US healthcare provider, securing an initial order for 150 of its Model A and Neo ventilators and related accessories. The de...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 28, 2026